SOPs NEEDED IN ADVANCE AS PROTECTION AGAINST FDA CRIMINAL INVESTIGATIONS
SOPs NEEDED IN ADVANCE AS PROTECTION AGAINST FDA CRIMINAL INVESTIGATIONS to prevent company personnel from waiving their Fourth Amendment rights against illegal search and seizure, D.C. lawyer John Fleder advised at a Food & Drug Law Institute conference June 23. "Have a lawyer develop and help implement standard operating procedures and other written guidance advising the employees" what actions to take when approached by FDA investigators, either at the firm or at their homes, Fleder recommended. Without such SOPs, Fleder said, "the employee may waive invaluable constitutional rights."
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth